Tribunal supports CIT(A) decisions, dismisses Revenue's appeal, partly allows assessee's cross-objections. Sections 40A(2)(a) and 14A additions deleted. Genuine expenses upheld. (A)

The Tribunal upheld the CIT(A)'s decisions in the case, dismissing the Revenue's appeal and partly allowing the assessee's cross-objections. The additions under Section 40A(2)(a) for excess payment to the Parent Company and disallowance under Section 14A were deleted, with the Tribunal emphasizing the lack of evidence for excessiveness or unreasonableness in the payments. Additionally, the Tribunal supported the deletion of the disallowance of marketing commission and advertisement give away, noting the genuine nature of the expenses and the appellant's prerogative in determining necessity.

---

---

Issues Involved:
1. Deletion of addition under Section 40A(2)(a) for excess payment to the Parent Company.
2. Re-computation of disallowance under Section 14A.
3. Deletion of addition on account of Advertisement give away.
4. Deletion of disallowance of marketing commission under Section 40A(2)(a).

Detailed Analysis:

1. Deletion of Addition under Section 40A(2)(a) for Excess Payment to the Parent Company:
The appellant challenged the CIT(A)'s decision to delete the addition made by the AO under Section 40A(2)(a) concerning an excess payment of Rs. 47.28 lakhs to Glaxo SmithKline (GSK). The AO had apportioned common costs based on the turnover of the two companies, determining a 2.01% expenditure rate. The CIT(A) found this method incorrect, noting that the turnover of GSK and the appellant arose from distinct products and that both entities were taxed at the same rate, making the exercise revenue-neutral. The CIT(A) referenced the Supreme Court's decision in CIT vs. Glaxo SmithKline Asia (P) Ltd., concluding no tax evasion occurred. The Tribunal upheld the CIT(A)'s decision, emphasizing that the AO failed to provide evidence that the payments were excessive or unreasonable.

2. Re-computation of Disallowance under Section 14A:
The AO disallowed Rs. 12.70 lakhs under Section 14A read with Rule 8D for earning tax-exempt income, which the CIT(A) directed to be re-computed reasonably. The Tribunal agreed with the CIT(A), noting that Rule 8D was not applicable for the year in question and that the CIT(A) had instructed the AO to act reasonably. The Tribunal restored the matter to the AO for a fair estimation of the expenditure related to tax-exempt income, dismissing the AO's appeal and partly allowing the assessee's cross-objection.

3. Deletion of Addition on Account of Advertisement Give Away:
The AO disallowed Rs. 16.99 lakhs claimed by the assessee for advertisement give away, questioning the necessity of such expenses when the assessee was already paying consignment commission to GSK. The CIT(A) found the expenditure well-supported by sufficient details and genuine, thus deleting the addition. The Tribunal upheld the CIT(A)'s decision, stating that determining the necessity of an expenditure is the assessee's prerogative, not the AO's. The Tribunal also noted that the AO had allowed similar claims in subsequent years.

4. Deletion of Disallowance of Marketing Commission under Section 40A(2)(a):
The AO disallowed Rs. 3.67 crores paid as marketing commission to GSK, arguing it was excessive under Section 40A(2)(a). The CIT(A) found that the AO had misinterpreted the common cost charges and ignored the separate agreement for marketing commission between the appellant and GSK. The Tribunal upheld the CIT(A)'s decision, noting that the AO did not provide data to support the claim of excessiveness and that the payment was made per the agreement, with no evidence of it being excessive or unreasonable.

Conclusion:
The Tribunal dismissed the Revenue's appeal and partly allowed the assessee's cross-objections, affirming the CIT(A)'s decisions on all grounds.

---